Clinical trial
Prograf/Advagraf Conversion Study in Kidney Pancreas Transplant Recipients
NCT01797341 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prograf/Advagraf Conversion Study in Kidney Pancreas Transplant Recipients
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- February 28, 2014
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney-pancreas transplantation